Kaia Health Raises $75 Million Series C to Optimize MSK and COPD Care in the U.S. and Europe
Kaia Health is announcing a $75 million Series C round (total raised to date: $125 million) to expand clinical capabilities and transform the treatment path for Musculoskeletal (MSK) and Chronic obstructive pulmonary disease (COPD) care…